Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study.
Steiner N, Göbel G, Mauser L, Mühlnikel L, Fischinger M, Künz T, Willenbacher W, Hetzenauer G, Rudzki J, Nussbaumer W, Mayer W, Gunsilius E, Kircher B, Wolf D, Nachbaur D. Steiner N, et al. Among authors: rudzki j. Cancers (Basel). 2023 Jan 18;15(3):608. doi: 10.3390/cancers15030608. Cancers (Basel). 2023. PMID: 36765566 Free PMC article.
Early autologous and allogeneic peripheral blood stem cell transplantation for adult patients with acute B and T cell precursor neoplasms: a 12-year single center experience.
Steiner N, Brunelli L, Hetzenauer G, Lindner B, Göbel G, Rudzki J, Peschel I, Nevinny-Stickel M, Nussbaumer W, Mayer W, Loacker L, Kircher B, Gunsilius E, Wolf D, Nachbaur D. Steiner N, et al. Among authors: rudzki j. Ann Hematol. 2021 Mar;100(3):809-816. doi: 10.1007/s00277-020-04391-x. Epub 2021 Jan 26. Ann Hematol. 2021. PMID: 33496839 Free PMC article.
Autologous stem cell transplantation following simultaneous liver and kidney transplantation in severe amyloid light chain amyloidosis associated with multiple myeloma: a case report.
Al-Zoairy R, Viveiros A, Zoller H, Schneeberger S, Oberhuber G, Gunsilius E, Tilg H, Wolf D, Rudzki JD. Al-Zoairy R, et al. Among authors: rudzki jd. J Med Case Rep. 2020 Oct 25;14(1):201. doi: 10.1186/s13256-020-02511-9. J Med Case Rep. 2020. PMID: 33099313 Free PMC article.
Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies.
Petzer V, Steiner N, Angelova-Unterberger O, Hetzenauer G, Philipp-Abbrederis K, Willenbacher E, Feistritzer C, Willenbacher W, Rudzki J, Stauder R, Kocher F, Seeber A, Pircher A, Tymoszuk P, Isara C, Egger A, Fux V, Anliker M, Gunsilius E, Nachbaur D, Schmidt S, Wolf D. Petzer V, et al. Among authors: rudzki j. Hemasphere. 2022 Feb 15;6(3):e686. doi: 10.1097/HS9.0000000000000686. eCollection 2022 Mar. Hemasphere. 2022. PMID: 35187405 Free PMC article. No abstract available.
Current treatment concepts of Philadelphia-negative MPN.
Wolf D, Rudzki J, Gastl G. Wolf D, et al. Among authors: rudzki j. Curr Cancer Drug Targets. 2011 Jan;11(1):44-55. doi: 10.2174/156800911793743592. Curr Cancer Drug Targets. 2011. PMID: 21062242 Review.
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Elsawy M, Chavez JC, Avivi I, Larouche JF, Wannesson L, Cwynarski K, Osman K, Davison K, Rudzki JD, Dahiya S, Dorritie K, Jaglowski S, Radford J, Morschhauser F, Cunningham D, Martin Garcia-Sancho A, Tzachanis D, Ulrickson ML, Karmali R, Kekre N, Thieblemont C, Enblad G, Dreger P, Malladi R, Joshi N, Wang WJ, Solem CT, Snider JT, Cheng P, To C, Kersten MJ. Elsawy M, et al. Among authors: rudzki jd. Blood. 2022 Nov 24;140(21):2248-2260. doi: 10.1182/blood.2022015478. Blood. 2022. PMID: 35839452 Free PMC article. Clinical Trial.
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma.
Locke FL, Miklos DB, Jacobson CA, Perales MA, Kersten MJ, Oluwole OO, Ghobadi A, Rapoport AP, McGuirk J, Pagel JM, Muñoz J, Farooq U, van Meerten T, Reagan PM, Sureda A, Flinn IW, Vandenberghe P, Song KW, Dickinson M, Minnema MC, Riedell PA, Leslie LA, Chaganti S, Yang Y, Filosto S, Shah J, Schupp M, To C, Cheng P, Gordon LI, Westin JR; All ZUMA-7 Investigators and Contributing Kite Members. Locke FL, et al. N Engl J Med. 2022 Feb 17;386(7):640-654. doi: 10.1056/NEJMoa2116133. Epub 2021 Dec 11. N Engl J Med. 2022. PMID: 34891224 Clinical Trial.
68 results